{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:11:11Z","timestamp":1789621871041,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Which factors are associated with low serum progesterone (P) levels on the day of frozen embryo transfer (FET), in HRT cycles?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>BMI, parity and non-European geographic origin are factors associated with low serum P levels on the day of FET in HRT cycles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>The detrimental impact of low serum P concentrations on HRT-FET outcomes is commonly recognized. However, the factors accounting for P level disparities among patients receiving the same luteal phase support treatment remain to be elucidated, to help clinicians predicting which subgroups of patients would benefit from a tailored P supplementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>Observational cohort study with 915 patients undergoing HRT-FET at a tertiary care university hospital, between January 2019 and March 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Patients undergoing single autologous blastocyst FET under HRT using exogenous estradiol and vaginal micronized progesterone for endometrial preparation. Women were only included once during the study period. The serum progesterone level was measured in the morning of the FET, in a single laboratory. Independent factors associated with low serum P levels (defined as \u22649.8\u2009ng\/ml, according to a previous published study) were analyzed using univariate and multivariate logistic regression models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Two hundred and twenty-six patients (24.7%) had a low serum P level, on the day of the FET. Patients with a serum P level \u22649.8\u2009ng\/ml had a lower live birth rate (26.1% vs 33.2%, P\u2009=\u20090.045) and a higher rate of early miscarriage (35.2% vs 21.5%, P\u2009=\u20090.008). Univariate analysis showed that BMI (P\u2009&amp;lt;\u20090.001), parity (P\u2009=\u20090.001), non-European geographic origin (P\u2009=\u20090.001), the duration of infertility (P\u2009=\u20090.018) and the use of oral estradiol for endometrial preparation (P\u2009=\u20090.009) were significantly associated with low serum P levels. Moreover, the proportion of active smokers was significantly lower in the \u2018low P concentrations\u2019 group (P\u2009=\u20090.002). After multivariate analysis, BMI (odds ratio (OR) 1.06 95% CI (1.02\u20131.11), P\u2009=\u20090.002), parity (OR 1.32 95% CI (1.04\u20131.66), P\u2009=\u20090.022), non-European geographic origin (OR 1.70 95% CI (1.21\u20132.39), P\u2009=\u20090.002) and active smoking (OR 0.43 95% CI (0.22\u20130.87), P\u2009=\u20090.018) remained independent factors associated with serum P levels \u22649.8\u2009ng\/ml.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The main limitation of this study is its observational design, leading to a risk of selection and confusion bias that cannot be ruled out, although a multivariable analysis was performed to minimize this.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Extrapolation of our results to other laboratories, or other routes and\/or doses of administering progesterone also needs to be validated. There is urgent need for future research on clinical factors affecting P concentrations and the underlying pathophysiological mechanisms, to help clinicians in predicting which subgroups of patients would benefit from individualized luteal phase support.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>No funding\/no conflicts of interest.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deac199","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T10:44:34Z","timestamp":1663670674000},"page":"2570-2577","source":"Crossref","is-referenced-by-count":34,"title":["Clinical factors associated with low serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cycles"],"prefix":"10.1093","volume":"37","author":[{"given":"C","family":"Maignien","sequence":"first","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-3493","authenticated-orcid":false,"given":"M","family":"Bourdon","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"},{"name":"Department \u201cDevelopment, Reproduction and Cancer\u201d, Cochin Institute, INSERM U1016 (Professor Batteux) , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Marcellin","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"},{"name":"Department \u201cDevelopment, Reproduction and Cancer\u201d, Cochin Institute, INSERM U1016 (Professor Batteux) , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Guibourdenche","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Biological Endocrinology, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chargui","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Histology and Reproductive Biology, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-8885","authenticated-orcid":false,"given":"C","family":"Patrat","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Histology and Reproductive Biology, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Plu-Bureau","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"},{"name":"Equipe EPOPE, INSERM U1153 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Chapron","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"},{"name":"Department \u201cDevelopment, Reproduction and Cancer\u201d, Cochin Institute, INSERM U1016 (Professor Batteux) , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4985-7326","authenticated-orcid":false,"given":"P","family":"Santulli","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de Sant\u00e9, Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin , Paris, France"},{"name":"Department \u201cDevelopment, Reproduction and Cancer\u201d, Cochin Institute, INSERM U1016 (Professor Batteux) , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"2022110206033661800_deac199-B1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.rbmo.2018.08.022","article-title":"Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes","volume":"37","author":"Alsbjerg","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2022110206033661800_deac199-B2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9378(95)90268-6","article-title":"Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone","volume":"173","author":"Archer","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2022110206033661800_deac199-B3","doi-asserted-by":"crossref","first-page":"686167","DOI":"10.3389\/fcimb.2021.686167","article-title":"The vaginal microbiome: a long urogenital colonization throughout woman life","volume":"11","author":"Auriemma","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2022110206033661800_deac199-B4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/humrep\/dey041","article-title":"Prolonged estrogen (E2) treatment prior to frozen-blastocyst transfer decreases the live birth rate","volume":"33","author":"Bourdon","year":"2018","journal-title":"Hum Reprod"},{"key":"2022110206033661800_deac199-B5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12958-019-0549-9","article-title":"Measuring the serum progesterone level on the day of transfer can be an additional tool to maximize ongoing pregnancies in single euploid frozen blastocyst transfers","volume":"17","author":"Boynukalin","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"2022110206033661800_deac199-B6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10815-014-0199-y","article-title":"Serum progesterone concentration on day of embryo transfer in donor oocyte cycles","volume":"31","author":"Brady","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"2022110206033661800_deac199-B7","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1210\/jc.2011-1165","article-title":"Cigarette smoking and endogenous sex hormones in postmenopausal women","volume":"96","author":"Brand","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022110206033661800_deac199-B8","doi-asserted-by":"crossref","first-page":"40.e1","DOI":"10.1016\/j.ajog.2011.03.028","article-title":"Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation","volume":"205","author":"Caritis","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2022110206033661800_deac199-B9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.rbmo.2018.11.026","article-title":"Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium","volume":"38","author":"C\u00e9drin-Durnerin","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2022110206033661800_deac199-B10","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.fertnstert.2010.04.020","article-title":"Smoking habits of 411 women with histologically proven endometriosis and 567 unaffected women","volume":"94","author":"Chapron","year":"2010","journal-title":"Fertil Steril"},{"key":"2022110206033661800_deac199-B11","doi-asserted-by":"crossref","first-page":"528202","DOI":"10.3389\/fimmu.2020.528202","article-title":"Recent insights on the maternal microbiota: impact on pregnancy outcomes","volume":"11","author":"Di Simone","year":"2020","journal-title":"Front Immunol"},{"key":"2022110206033661800_deac199-B12","first-page":"3","article-title":"Biomechanical mapping of the female pelvic floor: changes with age, parity and weight","volume":"38","author":"Egorov","year":"2019","journal-title":"Pelviperineology"},{"key":"2022110206033661800_deac199-B13","doi-asserted-by":"crossref","first-page":"hoaa032","DOI":"10.1093\/hropen\/hoaa032","article-title":"ART in Europe, 2016: results generated from European registries by ESHRE","volume":"2020","author":"European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2022110206033661800_deac199-B14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humrep\/dey004","article-title":"Live birth rate following frozen\u2013thawed blastocyst transfer is higher with blastocysts expanded on Day 5 than on Day 6","volume":"33","author":"Ferreux","year":"2018","journal-title":"Hum Reprod"},{"key":"2022110206033661800_deac199-B15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/09513590.2018.1534952","article-title":"Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates","volume":"35","author":"Gaggiotti-Marre","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2022110206033661800_deac199-B16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-0378(01)00136-X","article-title":"Physiology and culture of the human blastocyst","volume":"55","author":"Gardner","year":"2002","journal-title":"J Reprod Immunol"},{"key":"2022110206033661800_deac199-B17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.rbmo.2020.03.001","article-title":"Factors associated with serum progesterone concentrations the day before cryopreserved embryo transfer in artificial cycles","volume":"40","author":"Gonz\u00e1lez-Foruria","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"2022110206033661800_deac199-B18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.fertnstert.2018.02.135","article-title":"Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles","volume":"109","author":"Groenewoud","year":"2018","journal-title":"Fertil Steril"},{"key":"2022110206033661800_deac199-B19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humrep\/deu299","article-title":"Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group","volume":"30","author":"Kolte","year":"2015","journal-title":"Hum Reprod"},{"key":"2022110206033661800_deac199-B20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2014.06.013","article-title":"The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus","volume":"162","author":"La Rocca","year":"2014","journal-title":"Immunol Lett"},{"key":"2022110206033661800_deac199-B21","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/humrep\/dex316","article-title":"Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study","volume":"32","author":"Labarta","year":"2017","journal-title":"Hum Reprod Oxf Engl"},{"key":"2022110206033661800_deac199-B22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/deaa322","article-title":"Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in artificial cycles with vaginal progesterone","volume":"36","author":"Labarta","year":"2021","journal-title":"Hum Reprod"},{"key":"2022110206033661800_deac199-B23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fertnstert.2021.08.040","article-title":"Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles","volume":"117","author":"Labarta","year":"2022","journal-title":"Fertil Steril"},{"key":"2022110206033661800_deac199-B24","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/humrep\/deab184","article-title":"Analysis of serum and endometrial progesterone in determining endometrial receptivity","volume":"36","author":"Labarta","year":"2021","journal-title":"Hum Reprod"},{"key":"2022110206033661800_deac199-B25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/humrep\/deac017","article-title":"Are serum progesterone measurements truly representative for the identification of an adequate luteal phase in hormonal replacement therapy frozen embryo transfers?","volume":"37","author":"Lawrenz","year":"2022","journal-title":"Hum Reprod"},{"key":"2022110206033661800_deac199-B26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.rbmo.2021.11.007","article-title":"Low serum progesterone affects live birth rate in cryopreserved blastocyst transfer cycles using hormone replacement therapy","volume":"44","author":"Maignien","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"2022110206033661800_deac199-B27","article-title":"Infertility in women with bowel endometriosis: first-line assisted reproductive technology results in satisfactory cumulative live-birth rates","author":"Maignien","year":"2020","journal-title":"Fertil Steril"},{"key":"2022110206033661800_deac199-B28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.fertnstert.2018.08.047","article-title":"Effect of body weight on early hormone levels in singleton pregnancies resulting in delivery after in vitro fertilization","volume":"110","author":"Mejia","year":"2018","journal-title":"Fertil Steril"},{"key":"2022110206033661800_deac199-B29","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.fertnstert.2021.07.002","article-title":"Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis","volume":"116","author":"Melo","year":"2021","journal-title":"Fertil Steril"},{"key":"2022110206033661800_deac199-B30","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2013-3937","article-title":"Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert","volume":"99","author":"Paulson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2022110206033661800_deac199-B31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3389\/fimmu.2018.01293","article-title":"Progesterone modulation of pregnancy-related immune responses","volume":"9","author":"Shah","year":"2018","journal-title":"Front Immunol"},{"key":"2022110206033661800_deac199-B32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.contraception.2018.05.008","article-title":"Morbid obesity: potential effects of hormonal contraception","volume":"98","author":"Stanczyk","year":"2018","journal-title":"Contraception"},{"key":"2022110206033661800_deac199-B33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou","year":"2000","journal-title":"Hum Reprod Update"},{"key":"2022110206033661800_deac199-B34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000078842","article-title":"Pharmacokinetics of natural progesterone vaginal suppository","volume":"58","author":"von Eye Corleta","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"2022110206033661800_deac199-B35","first-page":"195","article-title":"The effect of weight and body mass index on serum progesterone values and live birth rate in cryopreserved in vitro fertilization cycles","volume":"2","author":"Whynott","year":"2021","journal-title":"F S Rep"},{"key":"2022110206033661800_deac199-B36","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The international glossary on infertility and fertility care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/11\/2570\/46694494\/deac199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/11\/2570\/46694494\/deac199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T06:04:04Z","timestamp":1667369044000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/11\/2570\/6705359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,9,19]]},"published-print":{"date-parts":[[2022,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac199","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,9,19]]}}}